Caxton Associates LP Dr Reddys Laboratories LTD Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $670,812 - $785,859	-13,519 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $652,562 - $882,114	13,519 New	13,519 $753,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $179,546 - $224,590	-2,983 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $185,303 - $221,338	2,983 New	2,983 $219,000

264

107M

71K

22.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.11B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.